Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Foster

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|April 15, 1988
An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Journal of in Vitro Fertilization and Embryo Transfer : IVF|August 1, 1989
Effect of bladder filling on embryo transferJ D Mitchell, P G Wardle, P A Foster, et al.
Blood|February 1, 1996
The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factorP A Kroner, P A Foster, S A Fahs, et al.
The Journal of Biological Chemistry|June 25, 1987
A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factorP A Foster, C A Fulcher, T Marti, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 1, 1992
The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrheaU M Fahy, P A Foster, H W Torode, et al.
The Journal of Clinical Investigation|July 1, 1988
Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chainP A Foster, C A Fulcher, R A Houghten, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1990
A murine monoclonal anti-factor VIII inhibitory antibody and two human factor VIII inhibitors bind to different areas within a twenty amino acid segment of the acidic region of factor VIII heavy chainP A Foster, C A Fulcher, R A Houghten, et al.
The Journal of Endocrinology|October 20, 2017
NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male miceE Meimaridou, M Goldsworthy, V Chortis, et al.
The Journal of Clinical Investigation|March 21, 1998
Intracellular trafficking of factor VIII to von Willebrand factor storage granulesJ B Rosenberg, P A Foster, R J Kaufman, et al.
Immunogenetics|December 29, 2000
Heterogeneity of RMA-S cell line: derivatives of RMA-S cells lacking H2-Kb and H2-Db expressionD Howell, J M Levitt, P A Foster, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|April 15, 1988
An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Journal of in Vitro Fertilization and Embryo Transfer : IVF|August 1, 1989
Effect of bladder filling on embryo transferJ D Mitchell, P G Wardle, P A Foster, et al.
Blood|February 1, 1996
The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factorP A Kroner, P A Foster, S A Fahs, et al.
The Journal of Biological Chemistry|June 25, 1987
A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factorP A Foster, C A Fulcher, T Marti, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 1, 1992
The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrheaU M Fahy, P A Foster, H W Torode, et al.
The Journal of Clinical Investigation|July 1, 1988
Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chainP A Foster, C A Fulcher, R A Houghten, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1990
A murine monoclonal anti-factor VIII inhibitory antibody and two human factor VIII inhibitors bind to different areas within a twenty amino acid segment of the acidic region of factor VIII heavy chainP A Foster, C A Fulcher, R A Houghten, et al.
The Journal of Endocrinology|October 20, 2017
NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male miceE Meimaridou, M Goldsworthy, V Chortis, et al.
The Journal of Clinical Investigation|March 21, 1998
Intracellular trafficking of factor VIII to von Willebrand factor storage granulesJ B Rosenberg, P A Foster, R J Kaufman, et al.
Immunogenetics|December 29, 2000
Heterogeneity of RMA-S cell line: derivatives of RMA-S cells lacking H2-Kb and H2-Db expressionD Howell, J M Levitt, P A Foster, et al.
Pageof 7